Halank M - Search Results

1

[Severe precapillary pulmonary hypertension in possible antiphospholipid syndrome--partially successful long-term therapy with continuous intravenous iloprost administration. A case report with discussion of new treatment methods].

Halank M, Rubens C, Ewert R, Höffken G, Braun J. Halank M, et al. Z Rheumatol. 2000 Oct;59(5):334-42. doi: 10.1007/s003930070056. Z Rheumatol. 2000. PMID: 11142929 German.

2

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?

Theobald V, Grünig E, Benjamin N, Seyfarth HJ, Halank M, Schneider MA, Richtmann S, Kazdal D, Hinderhofer K, Xanthouli P, Egenlauf B, Harutyunova S, Hoeper MM, Jonigk D, Sparla R, Muckenthaler MU, Eichstaedt CA. Theobald V, et al. Among authors: halank m. Pulm Circ. 2023 Jun 7;13(2):e12242. doi: 10.1002/pul2.12242. eCollection 2023 Apr. Pulm Circ. 2023. PMID: 37292089 Free PMC article.

3

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.

Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Hoeper MM, et al. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. N Engl J Med. 2023. PMID: 36877098 Clinical Trial.

4

[Precapillary pulmonary hypertension of uncertain etiology].

Halank M, Wiemer M, Tschöpe C, Poller W, Schwimmbeck P, Horstkotte D, Höffken G. Halank M, et al. Dtsch Med Wochenschr. 1998 Jul 10;123(28-29):861-5. doi: 10.1055/s-2007-1024078. Dtsch Med Wochenschr. 1998. PMID: 9693656 German.

5

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension.

Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, Hoeffken G. Rubens C, et al. Among authors: halank m. Chest. 2001 Nov;120(5):1562-9. doi: 10.1378/chest.120.5.1562. Chest. 2001. PMID: 11713135

6

[Sildenafil in pulmonary hypertension].

Ewert R, Höper M, Halank M, Winkler J, Wensel R, Opitz C. Ewert R, et al. Among authors: halank m. Pneumologie. 2003 May;57(5):291; author reply 291-2; discussion 292. Pneumologie. 2003. PMID: 12825577 German. No abstract available.

7

[Parapneumonic effusion and pleural empyema - topical aspects of classification, diagnosis and treatment].

Kolditz M, Halank M, Höffken G. Kolditz M, et al. Among authors: halank m. Pneumologie. 2004 Feb;58(2):83-91. doi: 10.1055/s-2003-812528. Pneumologie. 2004. PMID: 14961437 Review. German.

8

Long term survival in primary pulmonary hypertension.

Halank M, Marx C, Hoeffken G. Halank M, et al. Heart. 2004 Jul;90(7):e40. doi: 10.1136/hrt.2004.035725. Heart. 2004. PMID: 15201266 Free PMC article.

9

[Treatment of severe pneumonia--community-acquired and "early onset" nosocomial].

Höffken G, Halank M, Gillissen A. Höffken G, et al. Among authors: halank m. Med Klin (Munich). 2004 Jul 15;99(7):362-71. doi: 10.1007/s00063-004-1055-0. Med Klin (Munich). 2004. PMID: 15322715 Review. German.

10

Severe pulmonary hypertension in chronic idiopathic myelofibrosis.

Halank M, Marx C, Baretton G, Müller KM, Ehninger G, Höffken G. Halank M, et al. Onkologie. 2004 Oct;27(5):472-4. doi: 10.1159/000080368. Onkologie. 2004. PMID: 15585978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page